Synopsis
Synopsis
0
CEP/COS
0
VMF
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1,3-dimethyl-5-aminoadamantane
2. 1-amino-3,5-dimethyladamantane
3. Axura
4. D 145
5. D-145
6. D145
7. Ebixa
8. Memantin
9. Memantine
10. Namenda
1. 41100-52-1
2. Memantine Hcl
3. Namenda
4. 3,5-dimethyl-1-adamantanamine Hydrochloride
5. 3,5-dimethyladamantan-1-amine Hydrochloride
6. Akatinol
7. Axura
8. Namenda Xr
9. Memary
10. Ebixa
11. Memantine Mylan
12. 1-amino-3,5-dimethyladamantane Hydrochloride
13. Memantine Merz
14. Memantine.hcl
15. Memantine Accord
16. Memantine Lek
17. Memantine (hydrochloride)
18. Acrescent
19. Balaxur
20. Auxura
21. Unii-jy0wd0ua60
22. 3,5-dimethyladamantan-1-amine;hydrochloride
23. Jy0wd0ua60
24. Mfcd00214336
25. Memantine Ratiopharm
26. Memantine Hydrochloride [usan]
27. Chebi:64323
28. Sun-y7017
29. Nsc-102290
30. 3,5-dimethyladamantan-1-aminium Chloride
31. D-145
32. Mls001332605
33. 3,5-dimethyl-1-aminoadamantane Hydrochloride
34. (3,5-dimethyl-1-adamantyl)amine Hydrochloride
35. 3,5-dimethyltricyclo(3.3.1.1(3,7))decan-1-amine Hydrochloride
36. Fp-01
37. 1,3-dimethyl-5-adamantanamine Hcl
38. 3,5-dimethyltricyclo[3.3.1.13,7]decan-1-amine Hydrochloride
39. 41100-52-1 (hcl)
40. Tricyclo[3.3.1.13,7]decan-1-amine, 3,5-dimethyl-, Hydrochloride
41. D 145
42. Mantine
43. Ebixza
44. 3,5-dimethyl-tricyclo[3.3.1.13,7]decan-1-amine Hydrochloride
45. 3,5-dimethyltricyclo(3.3.1.13,7)decan-1-amine Hydrochloride
46. 3,5-dimethyltricyclo(3.3.1.1(sup 3,7))decan-1-amine Hydrochloride
47. Tricyclo(3.3.1.1(sup 3,7))decan-1-amine, 3,5-dimethyl-, Hydrochloride
48. 3,5-dimethyl-1-adamantylamine
49. 3,5-dimethyl-1-aminoadamantane
50. Smr000875213
51. Sr-01000075458
52. Sun Y7017
53. Einecs 255-219-6
54. Namenda (tn)
55. Memary (tn)
56. Marixino
57. Nsc 102290
58. D-145 (hydrochloride)
59. Schembl3053
60. C12h21n.hcl
61. Chembl1699
62. Mls001332606
63. Spectrum1501121
64. Hy-b0365a
65. Dtxsid90961439
66. Memantine Hydrochloride (namenda)
67. N06dx01
68. Nmi-131
69. Hms1571c17
70. Hms1921h03
71. Pharmakon1600-01501121
72. Memantine Hydrochloride (jan/usp)
73. Memantine Hydrochloride [mi]
74. Tox21_500861
75. Ac-559
76. Ccg-39018
77. Memantine Hydrochloride [jan]
78. Mrz-2/145
79. Nsc102290
80. Nsc757843
81. S2043
82. Akos015889460
83. Bcp9000253
84. Lp00861
85. Memantine Hydrochloride [mart.]
86. Nc00680
87. Memantine Hydrochloride [usp-rs]
88. Memantine Hydrochloride [who-dd]
89. Ncgc00094186-01
90. Ncgc00094186-02
91. Ncgc00094186-03
92. Ncgc00261546-01
93. As-13331
94. Bm164662
95. Memantine Hydrochloride [ema Epar]
96. Sy057917
97. 3,5-dimethyladamantan-1-aminehydrochloride
98. Am20070534
99. D3608
100. Eu-0100861
101. Ft-0650723
102. M-145
103. Memantine Hydrochloride [orange Book]
104. Sw060653-4
105. 1-amino-3,5-dimethyl-adamantane Hydrochloride
106. 3,5-dimethyladamantan-1-amine Hy-drochloride
107. 3,5-dimethyladamantan-1-amine;hydrochloride.
108. D04905
109. M 9292
110. Memantine Hydrochloride [usp Monograph]
111. Namzaric Component Memantine Hydrochloride
112. Memantine Hydrochloride Component Of Namzaric
113. Sr-01000075458-1
114. Sr-01000075458-3
115. Sr-01000075458-8
116. Q27133218
117. Z1551429722
118. Tricyclo(3.3.1.1(3,7))decan-1-amine, 3,5-dimethyl-, Hydrochloride
119. Tricyclo[3.3.1.13,7]decan-1-amine, 3,5-dimethyl-, Hydrochloride (1:1) (ca Index Name)
120. 1-amino-3,5-dimethyladamantane . Hcl 3,5-dimethyl-1-aminoadamantane . Hcl Memantine . Hydrochloride
| Molecular Weight | 215.76 g/mol |
|---|---|
| Molecular Formula | C12H22ClN |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | 215.1440774 g/mol |
| Monoisotopic Mass | 215.1440774 g/mol |
| Topological Polar Surface Area | 26 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 240 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 6 | |
|---|---|
| Drug Name | Memantine hydrochloride |
| PubMed Health | Memantine (By mouth) |
| Drug Classes | Central Nervous System Agent |
| Drug Label | Namenda (memantine hydrochloride) is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21N... |
| Active Ingredient | Memantine hydrochloride |
| Dosage Form | Tablet |
| Route | oral; Oral |
| Strength | 5mg; 10mg |
| Market Status | Tentative Approval |
| Company | Amneal Pharms; Alembic; Upsher Smith; Mylan Pharma; Unichem Pharms (usa); Apotex; Lupin Pharms; Aurobindo Pharma; Torrent Pharms; Macleods Pharms; Jubilant Life |
| 2 of 6 | |
|---|---|
| Drug Name | Namenda |
| PubMed Health | Memantine (By mouth) |
| Drug Classes | Central Nervous System Agent |
| Drug Label | Namenda (memantine hydrochloride) is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21N... |
| Active Ingredient | Memantine hydrochloride |
| Dosage Form | Tablet; Solution |
| Route | Oral |
| Strength | 2mg/ml; 5mg; 10mg |
| Market Status | Prescription |
| Company | Forest Labs |
| 3 of 6 | |
|---|---|
| Drug Name | Namenda xr |
| Drug Label | NAMENDA XR is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21NHCl and the molecular wei... |
| Active Ingredient | Memantine hydrochloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 7mg; 14mg; 21mg; 28mg |
| Market Status | Prescription |
| Company | Forest Labs |
| 4 of 6 | |
|---|---|
| Drug Name | Memantine hydrochloride |
| PubMed Health | Memantine (By mouth) |
| Drug Classes | Central Nervous System Agent |
| Drug Label | Namenda (memantine hydrochloride) is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21N... |
| Active Ingredient | Memantine hydrochloride |
| Dosage Form | Tablet |
| Route | oral; Oral |
| Strength | 5mg; 10mg |
| Market Status | Tentative Approval |
| Company | Amneal Pharms; Alembic; Upsher Smith; Mylan Pharma; Unichem Pharms (usa); Apotex; Lupin Pharms; Aurobindo Pharma; Torrent Pharms; Macleods Pharms; Jubilant Life |
| 5 of 6 | |
|---|---|
| Drug Name | Namenda |
| PubMed Health | Memantine (By mouth) |
| Drug Classes | Central Nervous System Agent |
| Drug Label | Namenda (memantine hydrochloride) is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21N... |
| Active Ingredient | Memantine hydrochloride |
| Dosage Form | Tablet; Solution |
| Route | Oral |
| Strength | 2mg/ml; 5mg; 10mg |
| Market Status | Prescription |
| Company | Forest Labs |
| 6 of 6 | |
|---|---|
| Drug Name | Namenda xr |
| Drug Label | NAMENDA XR is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21NHCl and the molecular wei... |
| Active Ingredient | Memantine hydrochloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 7mg; 14mg; 21mg; 28mg |
| Market Status | Prescription |
| Company | Forest Labs |
Treatment of patients with moderate to severe Alzheimer's disease.
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of patients with moderate to severe Alzheimer's disease.
Treatment of patients with moderate to severe Alzheimers disease
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of Alzheimers disease
Antiparkinson Agents
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)
Dopamine Agents
Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. (See all compounds classified as Dopamine Agents.)
Excitatory Amino Acid Antagonists
Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)
N06DX01
N06DX01
N06DX01
N06DX01
N06DX01
N06DX01
N06DX01
N06DX01
N06D
N06DA52
API SUPPLIERS
Delivering Quality APIs, Drug Intermediates, and Specialty Chemicals to Over 50 Countries Across the Globe.
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-02-07
Pay. Date : 2012-11-27
DMF Number : 20543
Submission : 2007-05-09
Status : Active
Type : II
Registration Number : 230MF10048
Registrant's Address : 5 Rupnicu Street, Olain, LV-2114, Latvia
Initial Date of Registration : 2018-03-30
Latest Date of Registration :
NDC Package Code : 63818-0004
Start Marketing Date : 2016-05-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Registrant Name : Eltek Pharmachem Co., Ltd.
Registration Date : 2020-05-22
Registration Number : 20200522-209-J-377
Manufacturer Name : JSC OlainFarm
Manufacturer Address : 5, Rupnicu Street, Olaine, LV-2114, Latvia
| Available Reg Filing : ASMF |
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-04-22
Pay. Date : 2019-02-11
DMF Number : 29180
Submission : 2015-03-16
Status : Active
Type : II
Date of Issue : 2022-08-25
Valid Till : 2025-07-02
Written Confirmation Number : WC-0195
Address of the Firm :
NDC Package Code : 76072-1004
Start Marketing Date : 2016-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2022-01-13
Registration Number : 20200304-209-J-395(3)
Manufacturer Name : ZCL Chemicals Limited
Manufacturer Address : 3102/B GIDC, Industrial Estate Ankleshwar-393 002, Dist. Bharuch, Gujarat State India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-11-13
Pay. Date : 2015-11-05
DMF Number : 20841
Submission : 2007-09-07
Status : Active
Type : II
NDC Package Code : 55111-860
Start Marketing Date : 2010-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
| Available Reg Filing : CA |
Jai Radhe Sales is your partner for all your sourcing needs.
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-11-23
Pay. Date : 2012-11-09
DMF Number : 20868
Submission : 2007-09-20
Status : Active
Type : II
| Available Reg Filing : CA, ASMF |
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Registration Number : 230MF10010
Registrant's Address : 5 Rupnicu Street, Olain, LV-2114, Latvia
Initial Date of Registration : 2018-01-24
Latest Date of Registration :
NDC Package Code : 63818-0004
Start Marketing Date : 2016-05-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Registrant Name : Eltek Pharmachem Co., Ltd.
Registration Date : 2020-05-22
Registration Number : 20200522-209-J-377
Manufacturer Name : JSC OlainFarm
Manufacturer Address : 5, Rupnicu Street, Olaine, LV-2114, Latvia
| Available Reg Filing : ASMF |
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-06-06
Pay. Date : 2013-05-22
DMF Number : 19549
Submission : 2006-06-20
Status : Active
Type : II
NDC Package Code : 17373-1146
Start Marketing Date : 2017-01-02
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-07
Pay. Date : 2012-11-27
DMF Number : 20543
Submission : 2007-05-09
Status : Active
Type : II
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2019-04-22
Pay. Date : 2019-02-11
DMF Number : 29180
Submission : 2015-03-16
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2015-11-13
Pay. Date : 2015-11-05
DMF Number : 20841
Submission : 2007-09-07
Status : Active
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Complete
Rev. Date : 2012-11-23
Pay. Date : 2012-11-09
DMF Number : 20868
Submission : 2007-09-20
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-06-06
Pay. Date : 2013-05-22
DMF Number : 19549
Submission : 2006-06-20
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19024
Submission : 2005-12-14
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-11-21
Pay. Date : 2013-04-23
DMF Number : 19465
Submission : 2006-05-22
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-06-19
Pay. Date : 2013-06-05
DMF Number : 18562
Submission : 2005-07-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20151
Submission : 2007-04-02
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-07-23
Pay. Date : 2013-07-08
DMF Number : 20362
Submission : 2007-03-23
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Date of Issue : 2022-08-25
Valid Till : 2025-07-02
Written Confirmation Number : WC-0195
Address of the Firm : Plot No. 3102/B, GIDC, Industrial Estate, Ankleshwar-393 002, Bharuch, Gujarat I...
Date of Issue : 2019-07-05
Valid Till : 2022-07-02
Written Confirmation Number : WC-0081
Address of the Firm : (API Division Panelav), Panelav, Tal-Halol, Dist-Panchmahal, Gujarat, India
Memantine Hydrochloride (USP/IH)
Date of Issue : 2019-08-09
Valid Till : 2025-08-08
Written Confirmation Number : WC-0066
Address of the Firm : Plot No. 1, Hetero SEZ Infrastructure Ltd., Narasapuram, Visakhapatnam-531 081, ...
Memantine Hydrochloride IH/USP
Date of Issue : 2022-07-27
Valid Till : 2025-07-21
Written Confirmation Number : WC-0087-(Annexure-1)
Address of the Firm : Plot No.1 to 5, 31 to 35 & 48 to 51, 26 & K/201, Village Lakhmapur, Taluka Dindo...
Date of Issue : 2019-08-16
Valid Till : 2025-08-15
Written Confirmation Number : WC-0022
Address of the Firm : Plot No. 212, A, B, C, D, IDA, Phase II, Pashamylaram (V), Patancheru (M), Sanga...
Date of Issue : 2020-03-13
Valid Till : 2023-01-05
Written Confirmation Number : WC-0384
Address of the Firm : Unit -IV Sy. No. 332,333 & 335, Velimindeu V Chityal Nalgonda District Telangan ...
Date of Issue : 2019-10-07
Valid Till : 2022-07-02
Written Confirmation Number : WC-0153
Address of the Firm : Plot No. L-6, MIDC, Taloja, Dist. Raigad, Maharastra
Date of Issue : 2022-06-08
Valid Till : 2025-07-25
Written Confirmation Number : WC-0159
Address of the Firm : A-7/A-8, MIDC, Ahmednagar-414 111, Maharashtra State
Memantine Hydrochloride IH/USP
Date of Issue : 2022-06-17
Valid Till : 2025-07-21
Written Confirmation Number : WC-0062
Address of the Firm : Plot No.197, Sector 1, Pithampur, Dist. Dhar, M.P
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - TABLET;ORAL - 10MG
USFDA APPLICATION NUMBER - 21487
DOSAGE - TABLET;ORAL - 5MG
USFDA APPLICATION NUMBER - 21487
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 14M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 14MG
USFDA APPLICATION NUMBER - 22525
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 21M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 21MG
USFDA APPLICATION NUMBER - 22525
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 28M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 28MG
USFDA APPLICATION NUMBER - 22525
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 7MG...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 7MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 22525
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Minakem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Chynops Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pramukh Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zeal MediPharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Alcedo Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Avesta Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Bioplus Life Sciences
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NEWEDGE Overseas
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Vasa Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Vertellus
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Coating Systems & Additives
Controlled & Modified Release
Disintegrants & Superdisintegrants
Thickeners and Stabilizers
Granulation
Direct Compression
Film Formers & Plasticizers
Lubricants & Glidants
Topical
Taste Masking
Solubilizers
Parenteral
Co-Processed Excipients
Empty Capsules
Chewable & Orodispersible Aids
Emulsifying Agents
Rheology Modifiers
API Stability Enhancers
Coloring Agents
Vegetarian Capsules
Surfactant & Foaming Agents
Soft Gelatin
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
US Patents
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
USP
ANALYTICAL
ABOUT THIS PAGE
24
PharmaCompass offers a list of Memantine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Memantine Hydrochloride manufacturer or Memantine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Memantine Hydrochloride manufacturer or Memantine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Memantine Hydrochloride API Price utilized in the formulation of products. Memantine Hydrochloride API Price is not always fixed or binding as the Memantine Hydrochloride Price is obtained through a variety of data sources. The Memantine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A memantine.HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of memantine.HCl, including repackagers and relabelers. The FDA regulates memantine.HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. memantine.HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of memantine.HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A memantine.HCl supplier is an individual or a company that provides memantine.HCl active pharmaceutical ingredient (API) or memantine.HCl finished formulations upon request. The memantine.HCl suppliers may include memantine.HCl API manufacturers, exporters, distributors and traders.
click here to find a list of memantine.HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A memantine.HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of memantine.HCl active pharmaceutical ingredient (API) in detail. Different forms of memantine.HCl DMFs exist exist since differing nations have different regulations, such as memantine.HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A memantine.HCl DMF submitted to regulatory agencies in the US is known as a USDMF. memantine.HCl USDMF includes data on memantine.HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The memantine.HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of memantine.HCl suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The memantine.HCl Drug Master File in Japan (memantine.HCl JDMF) empowers memantine.HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the memantine.HCl JDMF during the approval evaluation for pharmaceutical products. At the time of memantine.HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of memantine.HCl suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a memantine.HCl Drug Master File in Korea (memantine.HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of memantine.HCl. The MFDS reviews the memantine.HCl KDMF as part of the drug registration process and uses the information provided in the memantine.HCl KDMF to evaluate the safety and efficacy of the drug.
After submitting a memantine.HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their memantine.HCl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of memantine.HCl suppliers with KDMF on PharmaCompass.
A memantine.HCl written confirmation (memantine.HCl WC) is an official document issued by a regulatory agency to a memantine.HCl manufacturer, verifying that the manufacturing facility of a memantine.HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting memantine.HCl APIs or memantine.HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a memantine.HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of memantine.HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing memantine.HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for memantine.HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture memantine.HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain memantine.HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a memantine.HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of memantine.HCl suppliers with NDC on PharmaCompass.
memantine.HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of memantine.HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right memantine.HCl GMP manufacturer or memantine.HCl GMP API supplier for your needs.
A memantine.HCl CoA (Certificate of Analysis) is a formal document that attests to memantine.HCl's compliance with memantine.HCl specifications and serves as a tool for batch-level quality control.
memantine.HCl CoA mostly includes findings from lab analyses of a specific batch. For each memantine.HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
memantine.HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (memantine.HCl EP), memantine.HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (memantine.HCl USP).
